|
Valoración DCF de NUVation Bio Inc. (NUVB)
US | Healthcare | Biotechnology | NYSE
|
- ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
- ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
- ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
- ✓ No Se Necesita Experiencia; Fáciles De Seguir
Nuvation Bio Inc. (NUVB) Bundle
¡Explore las perspectivas financieras de Nuvation Bio Inc. (NUVB) con nuestra calculadora DCF fácil de usar! Ingrese sus suposiciones con respecto al crecimiento, los márgenes y los gastos para determinar el valor intrínseco de Nuvation Bio Inc. (NUVB) e informar sus decisiones de inversión.
Discounted Cash Flow (DCF) - (USD MM)
Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Revenue Growth, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBITDA | -32.1 | -43.4 | -89.3 | -119.5 | -99.6 | .0 | .0 | .0 | .0 | .0 |
EBITDA, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
Depreciation | .0 | .1 | .4 | .5 | .2 | .0 | .0 | .0 | .0 | .0 |
Depreciation, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
EBIT | -32.1 | -43.6 | -89.7 | -120.0 | -99.8 | .0 | .0 | .0 | .0 | .0 |
EBIT, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
Total Cash | 118.9 | 215.8 | 765.4 | 661.0 | 611.2 | .0 | .0 | .0 | .0 | .0 |
Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Account Receivables | .0 | 1.1 | 3.0 | 2.5 | 3.7 | .0 | .0 | .0 | .0 | .0 |
Account Receivables, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
Inventories | .0 | 2.9 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Inventories, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
Accounts Payable | 2.0 | 2.2 | 3.9 | 2.1 | 2.2 | .0 | .0 | .0 | .0 | .0 |
Accounts Payable, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
Capital Expenditure | -.7 | -.1 | -.3 | -.4 | -.1 | .0 | .0 | .0 | .0 | .0 |
Capital Expenditure, % | 100 | 100 | 100 | 100 | 100 | 0 | 0 | 0 | 0 | 0 |
Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBITAT | -32.1 | -41.3 | -82.4 | -102.1 | -99.8 | .0 | .0 | .0 | .0 | .0 |
Depreciation | ||||||||||
Changes in Account Receivables | ||||||||||
Changes in Inventories | ||||||||||
Changes in Accounts Payable | ||||||||||
Capital Expenditure | ||||||||||
UFCF | -30.7 | -45.2 | -79.5 | -103.2 | -100.8 | 1.5 | .0 | .0 | .0 | .0 |
WACC, % | 10.82 | 10.82 | 10.82 | 10.82 | 10.82 | 10.82 | 10.82 | 10.82 | 10.82 | 10.82 |
PV UFCF | ||||||||||
SUM PV UFCF | 1.3 | |||||||||
Long Term Growth Rate, % | 2.00 | |||||||||
Free cash flow (T + 1) | 0 | |||||||||
Terminal Value | 0 | |||||||||
Present Terminal Value | 0 | |||||||||
Enterprise Value | 1 | |||||||||
Net Debt | -39 | |||||||||
Equity Value | 40 | |||||||||
Diluted Shares Outstanding, MM | 219 | |||||||||
Equity Value Per Share | 0.18 |
What You Will Get
- Real Nuvation Bio Data: Preloaded financials – from revenue to EBIT – based on actual and projected figures.
- Full Customization: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
- Instant Valuation Updates: Automatic recalculations to analyze the impact of changes on Nuvation Bio’s fair value.
- Versatile Excel Template: Tailored for quick edits, scenario testing, and detailed projections.
- Time-Saving and Accurate: Skip building models from scratch while maintaining precision and flexibility.
Key Features
- Comprehensive Data: Nuvation Bio Inc.'s (NUVB) historical financial reports and pre-filled projections.
- Customizable Parameters: Modify WACC, tax rates, revenue growth, and EBITDA margins as needed.
- Real-Time Insights: Observe the recalculation of Nuvation Bio Inc.'s (NUVB) intrinsic value instantly.
- Intuitive Visualizations: Dashboard graphs showcase valuation outcomes and essential metrics.
- Designed for Precision: A reliable tool tailored for analysts, investors, and financial professionals.
How It Works
- Download the Template: Gain immediate access to the Excel-based Nuvation Bio Inc. (NUVB) DCF Calculator.
- Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and other key metrics.
- Instant Calculations: The model automatically recalculates Nuvation Bio Inc.’s intrinsic value.
- Test Scenarios: Experiment with various assumptions to assess potential valuation shifts.
- Analyze and Decide: Utilize the outcomes to inform your investment or financial decisions.
Why Choose Nuvation Bio Inc. (NUVB)?
- Innovative Solutions: Leverage cutting-edge technology for advanced biopharmaceutical development.
- Expert Team: Collaborate with industry leaders and experienced professionals in biotech.
- Robust Pipeline: Benefit from a diverse range of therapeutic candidates targeting unmet medical needs.
- Commitment to Quality: Adhere to the highest standards in research and development for reliable results.
- Growth Potential: Invest in a company poised for significant advancements in the biopharmaceutical landscape.
Who Should Use This Product?
- Individual Investors: Make informed decisions about buying or selling Nuvation Bio Inc. (NUVB) stock.
- Financial Analysts: Streamline valuation processes with ready-to-use financial models specific to Nuvation Bio Inc. (NUVB).
- Consultants: Deliver professional valuation insights on Nuvation Bio Inc. (NUVB) to clients quickly and accurately.
- Business Owners: Understand how biotech companies like Nuvation Bio Inc. (NUVB) are valued to guide your own strategy.
- Finance Students: Learn valuation techniques using real-world data and scenarios, including Nuvation Bio Inc. (NUVB).
What the Template Contains
- Pre-Filled DCF Model: Nuvation Bio Inc.'s (NUVB) financial data preloaded for immediate use.
- WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
- Financial Ratios: Evaluate Nuvation Bio Inc.'s (NUVB) profitability, leverage, and efficiency.
- Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
- Financial Statements: Annual and quarterly reports to support detailed analysis.
- Interactive Dashboard: Easily visualize key valuation metrics and results.